Skip to main content

Table 5 Surveillance detected cancer characteristics 

From: Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer– impact on patient anxiety and cancer detection

Study ID

Age range

Breast density (ACR)

Months since dx

Group

Abnormality

Detected by

BI-RADS

Histology

TNM

ER

PR

HER 2 neu

1

50 s

C

25

1

Ca + 

MG only

4A

DCIS, intermediate nuclear grade

Initial ca: IDC, ER-Her + 

-

   

2

80 s

B

216

2

Mass

A-MRI only

4B

DCIS, high nuclear grade

Initial ca: DCIS

-

   

3

40 s

C

37

2

Mass

A-MRI only

4B

IDC, grade 2/3

Initial ca: IDC, ER + Her-

T1c N0 M0

 + 

 + 

-

4

60 s

C

144

2

NME

A-MRI only

4B

Microinvasive lobular carcinoma, Pleomorphic lobular carcinoma in situ

Initial cancer: IDC, TN

T1miN0 M0

   

5

30 s

C

7

2

Mass

A-MRI only

5

IDC, grade 3/3

Initial ca: IDC, ER + Her + 

T3 N2 M0

-

-

 + 

6

70 s

C

120

2

Mass

A-MRI only

5

IDC, grade 2/3, DCIS

Initial Ca: IDC, TN

T2 Nx

 + 

-

-

7

50 s

B

33

2

Mass (lung)

A-MRI only

N/A

Adenocarcinoma consistent with breast cancer

Initial ca: IDC, ER + Her-

-

 + 

 + 

-

  1. Group 1: MG
  2. Group 2: MG plus A-MRI
  3. DCIS Ductal carcinoma in situ, IDC Invasive ductal carcinoma, TN Triple negative, ER Estrogen receptor, Her Herceptin receptor, NME Nonmass enhancement, NA Not applicable